Civic Intelligence

Society on Neuroimmune Pharmacology Inc

EIN 58-2586479 • 501(c)3 • Washington, DC

Profile

Organize Scientific Conferences

2300 Eye Street Ross Hall 502AWashington, DC 20037

www.s-nip.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

63rd percentile

9.4%

Higher net margin than 63% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

68th percentile

9.7%

Faster asset growth than 68% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

90th percentile

86%

Faster revenue growth than 90% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets60th percentile

Assets

Down

$109,589

Down $74,540 (-40%) from 2022

Liabilities

Flat

$0

Flat from 2022

Net Assets

-

No earlier filing loaded for comparison.

Operations
Liabilities / Revenue62nd percentileNet Margin63rd percentile

Revenue

Down

$61,201

Down $30,720 (-33%) from 2022

Expenses

Up

$135,741

Up $97,276 (+253%) from 2022

Net Income

Down

-$74,540

Down $127,996 (-239%) from 2022

Trend Graphs

Balance Sheet Trend

Asset Growth68th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2008: $10,743Liabilities 2008: $02008Assets 2009: $46,668Liabilities 2009: $02009Assets 2010: $62,306Liabilities 2010: $02010Assets 2011: $93,731Liabilities 2011: $02011Assets 2012: $107,835Net Assets 2012: $107,8352012Assets 2013: $140,780Net Assets 2013: $140,7802013Assets 2014: $199,786Net Assets 2014: $199,7862014Assets 2015: $199,047Net Assets 2015: $199,0472015Assets 2016: $202,262Liabilities 2016: $0Net Assets 2016: $202,2622016Assets 2017: $181,079Liabilities 2017: $0Net Assets 2017: $181,0792017Assets 2018: $73,108Liabilities 2018: $0Net Assets 2018: $73,1082018Assets 2019: $140,691Liabilities 2019: $0Net Assets 2019: $140,6912019Assets 2020: $135,399Liabilities 2020: $0Net Assets 2020: $135,3992020Assets 2022: $184,129Liabilities 2022: $0Net Assets 2022: $184,1292022Assets 2023: $109,589Liabilities 2023: $02023

Highlighted filing

2023

Assets$109,589
Liabilities$0
Net Assets-
Open 2023 Filing

Operations Trend

Revenue Growth90th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$300K$200K$100K$0-$100K-$200KRevenue 2008: $54,288Expenses 2008: $91,009Net Income 2008: -$36,7212008Revenue 2009: $121,167Expenses 2009: $85,242Net Income 2009: $35,9252009Revenue 2010: $134,317Expenses 2010: $118,679Net Income 2010: $15,6382010Revenue 2011: $139,191Expenses 2011: $107,766Net Income 2011: $31,4252011Revenue 2012: $130,697Expenses 2012: $116,593Net Income 2012: $14,1042012Revenue 2013: $194,247Expenses 2013: $161,302Net Income 2013: $32,9452013Revenue 2014: $129,624Expenses 2014: $70,618Net Income 2014: $59,0062014Revenue 2015: $123,137Expenses 2015: $123,876Net Income 2015: -$7392015Revenue 2016: $72,832Expenses 2016: $69,617Net Income 2016: $3,2152016Revenue 2017: $154,594Expenses 2017: $175,777Net Income 2017: -$21,1832017Revenue 2018: $86,744Expenses 2018: $194,715Net Income 2018: -$107,9712018Revenue 2019: $251,571Expenses 2019: $183,988Net Income 2019: $67,5832019Revenue 2020: $33,381Expenses 2020: $38,673Net Income 2020: -$5,2922020Revenue 2022: $91,921Expenses 2022: $38,465Net Income 2022: $53,4562022Revenue 2023: $61,201Expenses 2023: $135,741Net Income 2023: -$74,5402023

Highlighted filing

2023

Revenue$61,201
Expenses$135,741
Net Income-$74,540
Open 2023 Filing

Filings

Most recent year

2023 • Form 990EZSummary only. Only limited summary data is available for this year.

Open filing
Assets
$109,589
Liabilities
$0
Net assets
-
Revenue
$61,201
Expenses
$135,741
Net income
-$74,540
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Summary only. Only limited summary data is available for this year.$1.10$0.00$0.61$1.36$0.75
2022Detailed filing. Detailed filing data is available for this year.$1.84$0.00$1.84$0.92$0.38$0.53
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.35$0.00$1.35$0.33$0.39$0.05
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.41$0.00$1.41$2.52$1.84$0.68
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.73$0.00$0.73$0.87$1.95$1.08
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.81$0.00$1.81$1.55$1.76$0.21
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.02$0.00$2.02$0.73$0.70$0.03
2015Detailed filing. Detailed filing data is available for this year.$1.99$1.99$1.23$1.24$0.01
2014Detailed filing. Detailed filing data is available for this year.$2.00$2.00$1.30$0.71$0.59
2013Detailed filing. Detailed filing data is available for this year.$1.41$1.41$1.94$1.61$0.33
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$1.08$1.08$1.31$1.17$0.14
2011Summary only. Only limited summary data is available for this year.$0.94$0.00$1.39$1.08$0.31
2010Summary only. Only limited summary data is available for this year.$0.62$0.00$1.34$1.19$0.16
2009Summary only. Only limited summary data is available for this year.$0.47$0.00$1.21$0.85$0.36
2008Summary only. Only limited summary data is available for this year.$0.11$0.00$0.54$0.91$0.37
Latest Detailed Filing

The latest 2023 filing currently has summary financial data only. Showing the latest detailed filing from 2022 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Nov 1, 2023
Return Version
2022v5.0
Gross Receipts
$91,921
Mission and Program Overview

Mission

The mission of the SNIP is to: promote research and serve as a reliable source of information in the pharmacology, immunology, and neuroscience of the neuroimmune axis; foster exchange of information and ideas on neuroimmune pharmacology by holding an annual SNIP Conference, maintaining a Society web site (s-nip.org), and supporting and promoting the Society journal, the Journal of Neuroimmune Pharmacology (JNIP); encourage financial support from funding agencies, industry, and the SNIP membership to effect the SNIP mission.

Program Services

DescriptionGrantsExpenses
Sponsors a conference for attendees that presents new data, developments and technology in the fields of neuroimmunology and pharmacology.$0$33,885
Compensation and Service Providers
Top Officer Pay81st percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Nazira El-HageMembership Committee Chair-$0--
Ilker SariyerInterim Chair-$0--
Sowmya YelamanchiliInterim Chair-$0--
Gurudutt PendyalaEarly Career Investigator-$0--
Sulie ChangPresident-$0--
Santosh KumarPresident Elect-$0--
Sanjay MaggirwarTreasurer-$0--
Jean BidlackInterim Secretary-$0--
Filing and Contact Details

Filer

Filer Name
Society of Neuroimmune Pharmacology Inc
EIN
58-2586479
Phone
5852732276
Address
2300 Eye Street Ross Hall 502A, Washington, DC 20037

Signing Officer

Name
Sanjay Maggirwar
Title
Treasurer
Phone
5852732276
Signed
2023-11-01
Discuss with paid preparer
Yes

Preparer

Firm
Heveron & Company CPAs PLLC
Address
260 Plymouth Avenue South, Rochester, NY 14608
Preparer
John F Heveron Jr
Phone
5852322956
Supplemental Narrative

Additional Explanations

Form 990-EZ, Part I, Line 4 - Other Investment Income

“Description: Interest Income. Amount: 12.”

Form 990-EZ, Part I, Line 8 - Other Revenue

“Description: Royalties. Amount: 18,119. Description: Other Income. Amount: 1,167. Total to Form 990-EZ, line 8: 19,286.”

Form 990-EZ, Part I, Line 16 - Other Expenses

“Description: Travel/Hotel. Amount: 11,200. Description: Other Conference Expenses. Amount: 12,118. Description: Speaker Travel Expenses. Amount: 2,977. Description: Bank Service Fees. Amount: 2,230. Total to Form 990-EZ, line 16: 28,525.”

Raw XML Appendix208 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/PersonNm0Sanjay Maggirwar
IRS990EZ/BooksInCareOfDetail/PhoneNum05852732276
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0601 Elmwood Avenue Room 2-11134
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Rochester
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0NY
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd014642
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0130673
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0184129
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/ContributionsGiftsGrantsEtcAmt07500
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt053456
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt09940
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0130673
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0184129
IRS990EZ/GrossReceiptsAmt091921
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InvestmentIncomeAmt012
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0130673
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0184129
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0130673
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0184129
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt01.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt71.80
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt70
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Nazira El-Hage
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Ilker Sariyer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Sowmya Yelamanchili
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Gurudutt Pendyala
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Sulie Chang
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5Santosh Kumar
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6Sanjay Maggirwar
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm7Jean Bidlack
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Membership Committee Chair
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Interim Chair
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Interim Chair
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Early Career Investigator
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5President Elect
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt7Interim Secretary
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherChangesInNetAssetsAmt00
IRS990EZ/OtherExpensesTotalAmt028525
IRS990EZ/OtherRevenueTotalAmt019286
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0The mission of the SNIP is to: promote research and serve as a reliable source of information in the pharmacology, immunology, and neuroscience of the neuroimmune axis; foster exchange of information and ideas on neuroimmune pharmacology by holding an annual SNIP Conference, maintaining a Society web site (s-nip.org), and supporting and promoting the Society journal, the Journal of Neuroimmune Pharmacology (JNIP); encourage financial support from funding agencies, industry, and the SNIP membership to effect the SNIP mission.
IRS990EZ/ProgramServiceRevenueAmt065123
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Sponsors a conference for attendees that presents new data, developments and technology in the fields of neuroimmunology and pharmacology.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt033885
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt00
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt00
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt038465
IRS990EZ/TotalProgramServiceExpensesAmt033885
IRS990EZ/TotalRevenueAmt091921
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0www.s-nip.org
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0Royalty Income Other Societal Income
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0Schedule A, Part III, Line 12, Explanation of Other Income:
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt07500
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt07000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt019675
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt052375
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt086550
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt012
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt08
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt017
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt031
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt063
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0131
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt065123
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt026364
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0231865
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt034306
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0357658
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt012
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt08
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt017
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt031
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt063
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0131
IRS990ScheduleA/InvestmentIncomeCYPct00.00030
IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearAmt019286
IRS990ScheduleA/OtherIncome509Grp/TotalAmt019286
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.95810
IRS990ScheduleA/PublicSupportTotal509Amt0444208
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt072623
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt033364
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0251540
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt086681
IRS990ScheduleA/Total509Grp/TotalAmt0444208
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt091921
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt08
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt033381
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0251571
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt086744
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0463625
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Description: Interest Income. Amount: 12.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Description: Royalties. Amount: 18,119. Description: Other Income. Amount: 1,167. Total to Form 990-EZ, line 8: 19,286.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Description: Travel/Hotel. Amount: 11,200. Description: Other Conference Expenses. Amount: 12,118. Description: Speaker Travel Expenses. Amount: 2,977. Description: Bank Service Fees. Amount: 2,230. Total to Form 990-EZ, line 16: 28,525.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990-EZ, Part I, Line 4 - Other Investment Income
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990-EZ, Part I, Line 8 - Other Revenue
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990-EZ, Part I, Line 16 - Other Expenses
TransferPrsnlBnftContractsDecl/DeclarationDesc0The organization did not, during the year, receive any funds, directly,or indirectly, to pay premiums on a personal benefit contract.The organization, did not, during the year, pay any premiums, directly,or indirectly, on a personal benefit contract.
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0Sanjay Maggirwar
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Treasurer
ReturnHeader/BusinessOfficerGrp/PhoneNum05852732276
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-11-01
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0Society of Neuroimmune Pharmacology Inc
ReturnHeader/Filer/BusinessNameControlTxt0SOCI
ReturnHeader/Filer/EIN0582586479
ReturnHeader/Filer/PhoneNum05852732276
ReturnHeader/Filer/USAddress/AddressLine1Txt02300 Eye Street Ross Hall 502A
ReturnHeader/Filer/USAddress/CityNm0Washington
ReturnHeader/Filer/USAddress/StateAbbreviationCd0DC
ReturnHeader/Filer/USAddress/ZIPCd020037
ReturnHeader/IRSResponsiblePrtyInfoCurrInd00
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0271895149
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Heveron & Company CPAs PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0260 Plymouth Avenue South
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Rochester
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NY
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd014608
ReturnHeader/PreparerPersonGrp/PhoneNum05852322956
ReturnHeader/PreparerPersonGrp/PreparationDt02023-11-01
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0John F Heveron Jr
ReturnHeader/ReturnTs02023-11-06T08:58:42-06:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Sanjay
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0Maggirwar
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.